Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options

Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy...

Descripción completa

Detalles Bibliográficos
Autores principales: Isidro, Maria Luisa, Cordido, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991023/
https://www.ncbi.nlm.nih.gov/pubmed/27713245
http://dx.doi.org/10.3390/ph3010125
Descripción
Sumario:Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacologic treatment options.

Ejemplares similares